| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 104,017 | 87,760 | 80,240 | 95,005 | | Cost of Revenue | 16,539 | 15,937 | 14,661 | 16,066 | | | Gross Profit | 87,478 | 71,823 | 65,579 | 78,939 | | | Operating Expenses | | Research Development | 11,400 | 11,168 | 7,839 | 6,122 | | Selling General and Administrative | 45,693 | 44,157 | 44,874 | 51,501 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 30,385 | 16,498 | 12,866 | 21,316 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (301) | (1,490) | 681 | 1,159 | | Earnings Before Interest And Taxes | 30,084 | 15,008 | 13,547 | 22,475 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 30,084 | 15,008 | 13,547 | 22,475 | | Income Tax Expense | 8,730 | 5,055 | 4,888 | 8,638 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 21,354 | 9,953 | 8,659 | 13,837 | | | Non-recurring Events | | Discontinued Operations |
-
| 14 | 14,316 | 448 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 21,354 | 9,967 | 22,975 | 14,285 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $21,354 | $9,967 | $22,975 | $14,285 |
|
0.31% Nasdaq 
0.05%
Income Statement
